Chris Carpenter is an Executive Partner at Sofinnova Investments, where he invests across all stages of company formation—including clinical-stage, Series A–E, and post-IPO—in biopharma and life science therapeutics, with focus areas such as oncology and rare diseases. He invests in companies across the United States and Europe. He has invested in companies like Karuna Therapeutics, RayzeBio, Rapport Therapeutics, Capstan Therapeutics, and Aiolos Bio. Before Sofinnova, he was Chief Medical Officer at Catamaran Bio and Rubius Therapeutics; VP/SVP and Cancer Epigenetics DPU Head and Project Physician Leader at GSK/GlaxoSmithKline; and Director, Clinical Oncology at Merck. Earlier, he was an Assistant/Associate Professor of Medicine at Harvard Medical School. Chris studied at Stanford University and the University of Southern California, and lives in Cambridge, Massachusetts.
Chris Carpenter, Executive Partner @ Sofinnova. Profile with intro opportunities and ranking information.
Not Yet Mapped
We've created a profile for Chris Carpenter from Sofinnova Investments. Our ranking analysis and additional data will be available once our research is complete.
Rankings and detailed information coming soon
Network Strength
No ranking data available yet.
How to get an intro to Chris
Map your path to Chris instantly
Connect your network and Draftboard will automatically find and score the strongest paths to Chris
That's it. Draftboard does the rest.
Rankings based on connection strength analysis - we ONLY show aggregate data, never specific connection data.